TABLE 4.
FC-negative AD | FC-positive AD | Z score | p value | ||
n | 12 | 14 | |||
Age* | 66.08 ± 9.79 | 74.71 ± 12.32 | −2.04 | 0.044 | |
Gender (M/F) | 4:8 | 7:7 | 0.46 | ||
MMSE* | 17.00 ± 5.31 | 22.71 ± 2.84 | −2.51 | 0.012 | |
Cluster 1 | GMV | 5,687.31 ± 1,050.03 | 6,120.13 ± 920.18 | −0.93 | 0.374 |
SUVR* | 1.40 ± 0.13 | 1.22 ± 0.95 | −3.45 | 0.0005 | |
Cluster 2 | GMV | 6,981.53 ± 1,250.72 | 7,570.47 ± 1,135.87 | −1.18 | 0.237 |
SUVR* | 1.48 ± 0.13 | 1.31 ± 0.10 | −3.55 | 0.0009 |
*Age, MMSE scores, and SUVR in cluster 1 and cluster 2 for FC-negative AD vs. FC-positive AD patients were significantly different based on a two-sample t-test, p < 0.05. Data are means ± SD or numbers of subjects.